The enhancement of oxidative DNA damage by anti-diabetic metformin, buformin, and phenformin, via nitrogen-centered radicals.
Metformin (N,N-dimethylbiguanide), buformin (1-butylbiguanide), and phenformin (1-phenethylbiguanide) are anti-diabetic biguanide drugs, expected to having anti-cancer effect. The mechanism of anti-cancer effect by these drugs is not completely understood. In this study, we demonstrated that these drugs dramatically enhanced oxidative DNA damage under oxidative condition. Metformin, buformin, and phenformin enhanced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) in isolated DNA reacted with hydrogen peroxide (H2O2) and Cu(II), although these drugs did not form 8-oxodG in the absence of H2O2 or Cu(II). An electron paramagnetic resonance (EPR) study, utilizing alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone and 3,3,5,5-tetramethyl-1-pyrroline-N-oxide as spin trapping agents, showed that nitrogen-centered radicals were generated from biguanides in the presence of Cu(II) and H2O2, and that these radicals were decreased by the addition of DNA. These results suggest that biguanides enhance Cu(II)/H2O2-mediated 8-oxodG generation via nitrogen-centered radical formation. The enhancing effect on oxidative DNA damage may play a role on anti-cancer activity.
a Faculty of Pharmaceutical Sciences , Suzuka University of Medical Science , Suzuka , Mie , Japan ;
Shiho
S
Ohnishi
b College of Pharmacy , Kinjo Gakuin University , Nagoya , Aichi , Japan.
Hideki
H
Mizutani
a Faculty of Pharmaceutical Sciences , Suzuka University of Medical Science , Suzuka , Mie , Japan ;
Shosuke
S
Kawanishi
D000818:Animals; D002026:Buformin / Q000008:administration & dosage / Q000494:pharmacology*; D002417:Cattle; D004249:DNA Damage / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D008687:Metformin / Q000008:administration & dosage / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010629:Phenformin / Q000008:administration & dosage / Q000494:pharmacology*; D017382:Reactive Oxygen Species
D007004:Hypoglycemic Agents; D017382:Reactive Oxygen Species; D008687:Metformin; D010629:Phenformin; D002026:Buformin
8-OHdG; EPR; biguanide; cancer; oxidative stress